Genelux (GNLX) Return on Capital Employed (2023 - 2026)

Genelux's (GNLX) quarterly Return on Capital Employed came in at 187.59% in Q1 2026, up 10.86% quarter-over-quarter from 210.45% in Q4 2025.

Genelux (GNLX) Return on Capital Employed (2023 - 2026) Analysis & Trends

Genelux's Return on Capital Employed history runs 4 years deep, the most recent figure standing at 187.59% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed changed N/A year-over-year to 187.59% in Q1 2026; TTM through Mar 2026 was 187.59%, a N/A change from a year earlier, with the FY2025 full-year figure at 160.87%, down 3098.0% from the prior year.
  • Return on Capital Employed advanced to 187.59% in Q1 2026 per GNLX's latest filing, from 210.45% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 77.88% in Q3 2024 and bottomed at 210.45% in Q4 2025.
  • The 4-year median for Return on Capital Employed is 121.66% (2024), against an average of 131.85%.
  • Across the five-year window, Return on Capital Employed sank 469 bps in 2024 and plunged 10684 bps in 2025, its largest moves.
  • Year by year, Return on Capital Employed stood at 98.92% in 2023, then decreased by 5 bps to 103.62% in 2024, then plunged by 103 bps to 210.45% in 2025, then gained by 11 bps to 187.59% in 2026.
  • Per Business Quant, the three latest GNLX Return on Capital Employed figures stand at 187.59% (Q1 2026), 210.45% (Q4 2025), and 142.82% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -31.80%
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -107.40%
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 10.46%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 21.10%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 10.19%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -68.84%
10 Genelux 129.36 Mn 129.36 Mn - -187.59%

Historic Data

Download Data
DateValue
Mar 31, 2026 -187.59%
Dec 31, 2025 -210.45%
Sep 30, 2025 -142.82%
Dec 31, 2024 -103.62%
Sep 30, 2024 -77.88%
Jun 30, 2024 -93.79%
Mar 31, 2024 -139.71%
Dec 31, 2023 -98.92%